Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004

Journal of Affective Disorders

Volumn 99, Issue 1-3, 2007, Pages 9-17

  Wolfsperger, Marcus ^a   Greil, Waldemar ^a,b   Rössler, Wulf ^c   Grohmann, Renate ^b  

^a Sanatorium Kilchberg   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Anticonvulsants; Antidepressants; Antipsychotics; Lithium; Mania; Prescription

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; TRANQUILIZER; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRIA; CLINICAL PRACTICE; EUPHORIC MANIA; EVIDENCE BASED PRACTICE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL PATIENT; MIXED STATE MANIA; PRESCRIPTION; PRIORITY JOURNAL; SWITZERLAND; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; AUSTRIA; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; DRUG TOXICITY; EUPHORIA; FEMALE; GERMANY; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; SWITZERLAND; TRANQUILIZING AGENTS;

EID: 33847011000     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.08.017     Document Type: Article

References (42)

1. Adler L., Ulrich M., Lehmann K., Nordeck I., Langer C., Thomas R.S., Hajak G., and Koller M. Praxis der stationären Akutbehandlung von Manien. Retrospektive Vergleichsuntersuchung an je 100 Patienten zweier psychiatrischer Zentren. Fortschr. Neurol. Psychiatr. 62 (1994) 479-488
2. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am. J. Psychiatry 151 (1994) S1-S36
3. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159 (2002) S1-S50
4. Andrade C. Antidepressant-withdrawal mania: a critical review and synthesis of the literature. J. Clin. Psychiatry 65 (2004) 987-993
5. Bauer M.S., Callahan A.M., Jampala C., Petty F., Sajatovic M., Schaefer V., Wittlin B., and Powell B.J. Clinical practice guidelines for bipolar disorder from the department of veterans affairs. J. Clin. Psychiatry 60 (1999) 9-21
6. Berk M., Ichim L., and Brook S. Olanzapine compared to lithium in mania. A double-blind randomized controlled trial. Int. Clin. Psychopharmacol. 14 (1999) 339-343
7. Bowden C. The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers. J. Affect. Disord. 79 (2004) S9-S14
8. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Risch S.C., Goodnick P.J., and Morris D.D. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J. Am. Med. Assoc. 271 (1994) 918-924
9. Bowden C.L., Grunze H., Mullen J., Brecher M., Paulsson B., Jones M., Vagero M., and Svensson K. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J. Clin. Psychiatry 66 (2005) 111-121
10. Brown D., Silverstone T., and Cookson J. Carbamazepine compared to haloperidol in acute mania. Int. Clin. Psychopharmacol. 4 (1989) 229-238
11. Frances A., Docherty J.P., and Kahn D.A. Treatment of bipolar disorder. J. Clin. Psychiatry 57 Suppl 12A (1996) 3-88
12. Freeman T.W., Clothier J.L., Pazzaglia P., Lesem M.D., and Swann A.C. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am. J. Psychiatry 149 (1992) 108-111
13. Frye M.A., Ketter T.A., Leverich G.S., Huggins T., Lantz C., Denicoff K.D., and Post R.M. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J. Clin. Psychiatry 61 (2000) 9-15
14. Gelenberg A.J., and Hopkins H.S. Antipsychotics in bipolar disorder. J. Clin. Psychiatry 57 Suppl. 9 (1996) 49-52
15. Ghaemi S.N., and Katzow J.J. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann. Clin. Psychiatry 11 (1999) 137-140
16. Ghaemi S.N., and Goodwin F.K. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature. J. Clin. Psychopharmacol. 19 (1999) 354-361
17. Ghaemi S.N., Boiman E.E., and Goodwin F.K. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J. Clin. Psychiatry 61 (2000) 804-808
18. Goldstein T.R., Frye M.A., Denicoff K.D., Smith-Jackson E., Leverich G.S., Bryan A.L., Ali S.O., and Post R.M. Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. J. Clin. Psychiatry 60 (1999) 563-567
19. Goodwin G.M. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 17 (2003) 149-173
20. Grohmann R., Müller-Oerlinghausen B., and Rüther E. Editorial. Pharmacopsychiatry 37 Suppl. 1 (2004) S1
21. Grunze H., Walden J., Dittmann S., Berger M., Bergmann A., Bräunig P., Dose M., Emrich H.M., Gastpar M., Greil W., Krüger S., Möller H.J., and Uebelhack R. Psychopharmakotherapie bipolarer affektiver Erkrankungen. Nervenarzt 73 (2002) 4-19
22. Grunze H., Kasper S., Goodwin G., Bowden C., Baldwin D., Licht R.W., Vieta E., and Möller H.J. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J. Biol. Psychiatry 4 (2003) 5-13
23. Hummel B., Walden J., Stampfer R., Dittmann S., Amann B., and Sterr A. Acute manic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Bipolar Disord. 4 (2002) 412-417
24. Ichim L., Berk M., and Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann. Clin. Psychiatry 12 (2000) 5-10
25. Kane J.M. The role of neuroleptics in manic-depressive illness. J. Clin. Psychiatry 49 Suppl. 11 (1988) 12-13
26. Kusumakar V., Yatham L.N., Haslam D.R.S., Parikh S.V., Matte R., Silverstone P.H., and Sharma V. Treatment of mania, mixed state, and rapid cycling. Can. J. Psychiatry 42 Suppl. 2 (1997) 79S-86S
27. Levine J., Chengappa K.N.R., Brar J.S., Gershon S., Yablonsky E., Stapf D., and Kupfer D.J. Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord. 2 (2000) 120-130
28. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J. Affect. Disord. 50 (1998) 245-251
29. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry 164 (1994) 549-550
30. Pope H.G., McElroy S.L., Keck P.E., and Hudson J.I. Valproate in the treatment of acute mania. A placebo-controlled study. Arch. Gen. Psychiatry 48 (1991) 62-68
31. Ravindran A.V., Jones B.W., Al-Zaid K., and Lapierre Y.D. Effective treatment of mania with olanzapine: 2 case reports. J. Psychiatry Neurosci. 22 (1997) 345-346
32. Sachs G.S. Decision tree for the treatment of bipolar disorder. J. Clin. Psychiatry 64 Suppl. 8 (2003) 35-40
33. Sachs G.S., Printz D.J., Kahn D.A., Carpenter D., and Docherty J.P. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad. Med. Special Report April 2000 (2000) 1-104
34. Sachs G.S., Grossman F., Ghaemi S.N., Okamoto A., and Bowden C.L. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry 159 (2002) 1146-1154
35. Segal J., Berk M., and Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin. Neuropharmacol. 21 (1998) 176-180
36. Sernyak M.J., Griffin R.A., Johnson R.M., Pearsall H.R., Wexler B.E., and Woods S.W. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am. J. Psychiatry 151 (1994) 133-135
37. Small J.G., Klapper M.H., Milstein V., Kellams J.J., Miller M.J., Marhenke J.D., and Small I.F. Carbamazepine compared with lithium in the treatment of mania. Arch. Gen. Psychiatry 48 (1991) 915-921
38. Suppes T., Swann A.C., Dennehy E.B., Habermacher E.D., Mason M., Crismon M.L., Toprac M.G., Rush A.J., Shon S.P., and Altshuler K.Z. Texas medication algorithm project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J. Clin. Psychiatry 62 (2001) 439-447
39. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., and Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 156 (1999) 702-709
40. Tohen M., Chengappa K.N., Suppes T., Zarate C.A., Calabrese J.R., Bowden C.L., Sachs G.S., Kupfer D.J., Baker R.W., Risser R.C., Keeter E.L., Feldmann P.D., Tollefson G.D., and Breier A. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch. Gen. Psychiatry 59 (2002) 62-69
41. Weisler R.H., Ahearn E.P., Davidson J.R., and Wallace C.D. Adjunctive use of olanzapine in mood disorders: five case reports. Ann. Clin. Psychiatry 9 (1997) 259-262
42. Yatham L.N., Paulsson B., Mullen J., and Vagero A.M. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J. Clin. Psychopharmacol. 24 (2004) 599-606